查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太机器人神经外科市场：分析与预测（2025-2035）
市场调查报告书
商品编码
1781121

亚太机器人神经外科市场：分析与预测（2025-2035）

Asia-Pacific Robotic Neurosurgery Market: Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 71 Pages | 商品交期: 1-5个工作天内

价格

亚太地区机器人神经外科市场规模预计将从 2025 年的 9,260 万美元增至 2035 年的 5.87 亿美元，预测期内的复合年增长率为 20.28%。

该地区神经系统疾病发生率的上升推动了机器人神经外科手术的扩张，也增加了对先进精准手术技术的需求。人工智慧、即时影像技术的融合以及精准度的提升等技术创新正在显着改善手术效果，并拓展手术技术的可能性。

主要市场统计数据
预测期 2025-2035
2025年评估 9260万美元
2035年预测 5.87亿美元
复合年增长率 20.28%

微创手术日益普及，进一步加速了机器人神经外科手术的普及，因为这些手术降低了手术风险并缩短了患者的恢復时间。此外，该地区快速发展的医疗基础设施，尤其是在新兴经济体，也为其应用创造了有利的环境。此外，本地和国际公司之间日益增长的策略伙伴关係以及不断增加的研发投入，正在刺激技术创新并扩大市场准入。这使得机器人神经外科手术成为该地区的关键成长领域。

该地区的机器人神经外科手术市场已成为成长最快的外科手术机器人领域之一。脑肿瘤、癫痫和帕金森氏症等神经系统疾病的发生率不断上升，推动了对先进、高精度外科手术的需求。对于该地区（无论是已开发经济体还是新兴经济体）的医疗保健专业人士而言，机器人神经外科手术因其高精度、微创性和改善患者预后的优势，已成为一个颇具吸引力的选择。

人工智慧、即时影像处理和触觉回馈设备等技术的发展，改善了操作员的控制和视觉化，正在彻底改变神经外科。微创手术具有恢復时间更短、併发症更少、住院时间更短等优势，因此也推动了机器人系统的普及。

新兴经济体，尤其是中国、印度和东南亚，正在大力投资医疗基础设施，政府的支持和私营部门的创新加速了市场渗透。此外，本地公司正在开发符合当地需求、价格合理的机器人系统，这有助于提高先进神经外科治疗的可近性。在临床应用不断扩展和报销机制更加优惠的推动下，亚太地区机器人神经外科市场预计将在长期内实现显着成长。

市场区隔:

细分 1：按产品类型

  • 机器人系统
  • 服务
  • 设备和配件

细分2：按地区

  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 其他的

本报告研究了亚太地区的机器人神经外科市场，并总结了主要趋势、市场影响因素分析、法律制度、技术和专利分析、市场规模趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局和主要企业的概况。

目录

执行摘要

范围和定义

第一章 机器人神经外科市场：产业展望

  • 趋势：现况与未来影响评估
    • 机器人神经外科手术的采用率不断提高
    • 公司之间开展了许多合作
    • 增加产品发布和监管核准
  • 供应链概览
  • 法律规范
    • 日本
    • 中国
  • 定价分析
    • 案例研究：Brain Navi 的 NaoTrac 完成 100 例神经外科手术
  • 资金筹措方案
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会

第 2 章：机器人神经外科手术市场（按地区）

  • 区域摘要
  • 亚太地区
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 治疗次数
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的

第三章市场：竞争基准化分析与公司概况

  • 产品基准
  • 关键策略和发展
  • 公司简介
    • KUKA AG (Midea Group)
    • Beijing Baihui Weikang Technology Co., Ltd.
    • Brain Navi Biotechnology Co. Ltd
    • Beijing Tinavi Medical Technologies Co., Ltd.

第四章调查方法

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Robotic Neurosurgery Market

The Asia-Pacific robotic neurosurgery market is projected to reach $587.0 million in 2035 and estimated $92.6 million in 2025, growing at a CAGR of 20.28% during the forecast period 2025-2035. The rising prevalence of neurological conditions in the APAC area is fuelling the expansion of robotic neurosurgery and raising the need for sophisticated and accurate surgical techniques. Technological developments are greatly enhancing surgical results and increasing procedural capabilities. Examples of these developments include AI integration, real-time imaging, and improved precision.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$92.6 Million
2035 Forecast$587.0 Million
CAGR20.28%

The increasing popularity of minimally invasive procedures is speeding up adoption even more because they lower surgical risks and recuperation periods for patients. Additionally, a favourable deployment environment is being created by the rapid expansion of healthcare infrastructure throughout emerging APAC markets. Furthermore, increasing R&D expenditures and strategic partnerships between regional and international businesses are stimulating innovation and expanding market accessibility, making robotic neurosurgery a vital area of expansion in the healthcare sector in Asia-Pacific.

Market Introduction

The Asia-Pacific (APAC) robotic neurosurgery industry is emerging as one of the region's fastest-growing surgical robotics segments. The need for sophisticated, high-precision surgical procedures is growing as neurological conditions like brain tumours, epilepsy, and Parkinson's disease become more common. Healthcare professionals in both established and developing APAC nations find robotic neurosurgery to be a tempting alternative due to its increased accuracy, decreased invasiveness, and improved patient outcomes.

Technological developments that provide surgeons more control and visualisation, such as the incorporation of artificial intelligence, real-time imaging, and haptic feedback devices, are transforming neurosurgery procedures. The deployment of robotic systems is being further fuelled by the region's trend towards minimally invasive surgeries, which have advantages like quicker recovery times, less problems, and shorter hospital stays.

Market penetration is being accelerated by rising investments in healthcare infrastructure, especially in developing nations like China, India, and Southeast Asia, as well as encouraging government programs and rising private-sector innovation. Furthermore, local producers are creating affordable robotic systems that are suited to local requirements, increasing access to cutting-edge neurosurgical treatment. The market for robotic neurosurgery in APAC is expected to increase significantly over the long run due to expanding clinical applications and better reimbursement regulations.

Market Segmentation

Segmentation 1: by Product Type

  • Robotic Systems
  • Services
  • Instruments and Accessories

Segmentation 2: by Region

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

APAC Robotic Neurosurgery Market Trends, Drivers and Challenges

Market Trends

  • APAC is the fastest-growing region in the global robotic neurosurgery market, with a strong CAGR projection.
  • Increasing adoption of robotic neurosurgery in ambulatory surgical centers and specialty clinics.
  • Surge in domestic robotic system development by regional players, leading to more affordable solutions.
  • Growing demand for minimally invasive and AI-integrated neurosurgical procedures.
  • Broader procedural applications such as spinal surgeries, brain tumor removal, and deep brain stimulation.

Key Drivers

  • Rising prevalence of neurological disorders like stroke, brain tumors, and Parkinson's disease.
  • Expanding healthcare infrastructure and increasing healthcare investments across APAC.
  • Advancements in surgical robotics, including improved imaging, navigation, and AI-powered systems.
  • Cost-effective robotic systems developed by regional players expanding accessibility.
  • Increasing number of trained neurosurgeons and improved medical education frameworks.

Major Challenges

  • High capital investment and maintenance costs limit adoption, especially in smaller hospitals.
  • Limited or inconsistent reimbursement policies across APAC countries.
  • Shortage of skilled professionals trained in robotic neurosurgery.
  • Complex and fragmented regulatory pathways across different countries in the region.
  • Rapid technological evolution creates pressure for frequent system upgrades.
  • Safety, ethical, and liability concerns related to robotic-assisted surgeries.

How can this report add value to an organization?

Product/Innovation Strategy: The APAC robotic neurosurgery market has been extensively segmented based on various categories, such as product type, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The APAC robotic neurosurgery market has numerous established players with product and service portfolios. Key players in the APAC robotic neurosurgery market, as analyzed and profiled in the study, include established companies offering robotic neurosurgery systems, instruments, accessories, and services.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the market include:

  • KUKA AG (Midea Group)
  • Beijing Baihui Weikang Technology Co., Ltd.
  • Brain Navi Biotechnology Co. Ltd
  • Beijing Tinavi Medical Technologies Co., Ltd.

Table of Contents

Executive Summary

Scope and Definition

1 Robotic Neurosurgery Market: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Adoption of Robotic Neurosurgery Procedures
    • 1.1.2 Significant Number of Collaborations among Market Players
    • 1.1.3 Growing Number of Product Launch and Regulatory Approvals
  • 1.2 Supply Chain Overview
  • 1.3 Regulatory Framework
    • 1.3.1 Japan
    • 1.3.2 China
  • 1.4 Pricing Analysis
    • 1.4.1 Case Study: Brain Navi's NaoTrac Reaches 100 Neurosurgical Procedures Milestone
  • 1.5 Funding Scenario
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
      • 1.6.1.2 Rising Prevalence of Neurological Disorders
      • 1.6.1.3 Continuous Technological Advancements in Robotic Neurosurgery
    • 1.6.2 Market Restraints
      • 1.6.2.1 High Cost of Investment
      • 1.6.2.2 Lack of Skilled Professionals
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Development of Long-Distance Teleoperated Surgical Robotic Systems

2 Robotic Neurosurgery Market (by Region), $Million, 2023-2035

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 Procedure Volume
    • 2.2.5 China
    • 2.2.6 Japan
    • 2.2.7 India
    • 2.2.8 Australia
    • 2.2.9 South Korea
    • 2.2.10 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Product Benchmarking
  • 3.2 Key Strategies and Development
  • 3.3 Company Profiles
    • 3.3.1 KUKA AG (Midea Group)
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Products/Product Portfolio
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Target Customers
      • 3.3.1.5 Key Personal
      • 3.3.1.6 Analyst View
    • 3.3.2 Beijing Baihui Weikang Technology Co., Ltd.
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Target Customers
      • 3.3.2.5 Key Personal
      • 3.3.2.6 Analyst View
    • 3.3.3 Brain Navi Biotechnology Co. Ltd
      • 3.3.3.1 Overview
      • 3.3.3.2 Top Products/Product Portfolio
      • 3.3.3.3 Top Competitors
      • 3.3.3.4 Target Customers
      • 3.3.3.5 Key Personal
      • 3.3.3.6 Analyst View
    • 3.3.4 Beijing Tinavi Medical Technologies Co., Ltd.
      • 3.3.4.1 Overview
      • 3.3.4.2 Top Products/Product Portfolio
      • 3.3.4.3 Top Competitors
      • 3.3.4.4 Target Customers
      • 3.3.4.5 Key Personal
      • 3.3.4.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Robotic Neurosurgery Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Asia-Pacific Robotic Neurosurgery Market (by Product Type), $Million, 2023, 2028, and 2035
  • Figure 3: Supply Chain and Risks within the Supply Chain
  • Figure 4: Japan Federation of Medical Devices Associations (JFMDA) Classification
  • Figure 5: NMPA Classification
  • Figure 6: Robotic Neurosurgery Market, Patent Analysis (by Year), January 2019-April 2025
  • Figure 7: Impact Analysis of Market Navigating Factors, 2024-2035
  • Figure 8: Incidences of Neurological Disorders, Thousands, 2018-2021
  • Figure 9: Prevalence of Neurological Disorders (by Type of Neurological Disease), Thousands, 1990-2019
  • Figure 10: Prevalence of Parkinson's Disease, Region (2016-2021)
  • Figure 11: Timeline of the FDA Approvals for Various Robotic Neurosurgery Systems
  • Figure 12: Asia-Pacific Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 13: Asia-Pacific Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 14: Asia-Pacific Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 15: Asia-Pacific Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 16: Incidences of Neurological Disorders in China, 2018-2021
  • Figure 17: China Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 18: China Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 19: Incidences of Neurological Disorders in Japan, 2018-2021
  • Figure 20: Japan Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 21: Japan Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 22: Incidences of Neurological Disorders in India, 2018-2021
  • Figure 23: India Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 24: India Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 25: Incidences of Neurological Disorders in Australia, 2018-2021
  • Figure 26: Australia Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 27: Australia Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 28: Incidences of Neurological Disorders in South Korea, 2018-2021
  • Figure 29: South Korea Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 30: South Korea Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 31: Rest-of-Asia-Pacific Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 32: Rest-of-Asia-Pacific Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 33: Strategic Initiatives, January 2022-April 2025
  • Figure 34: Data Triangulation
  • Figure 35: Top-Down and Bottom-Up Approach
  • Figure 36: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Competitive Landscape Snapshot
  • Table 3: Robotic Neurosurgery Market Trend Analysis
  • Table 4: Some of the Partnerships and Collaborations in the Robotic Neurosurgery Market
  • Table 5: Some of the Product Launch and Regulatory Approvals in the Robotic Neurosurgery Market
  • Table 6: Medical Devices in Japan
  • Table 7: Costs of Neurosurgery Robotic Systems
  • Table 8: Funding Scenario of Neurosurgery Robotic Systems
  • Table 9: Comparison of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
  • Table 10: Comparison Between Various Navigation Systems Cost Breakdown of Robotic Neurosurgery Systems
  • Table 11: Robotic Neurosurgery Market (by Region), $Million, 2023-2035
  • Table 12: Asia-Pacific Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 13: Incidences of Neurological Disorders in China, By Disease Type, 2018-2021
  • Table 14: Incidences of Neurological Disorders in Japan, By Disease Type, 2018-2021
  • Table 15: Incidences of Neurological Disorders in India, By Disease Type, 2018-2021
  • Table 16: Incidences of Neurological Disorders in Australia, By Disease Type, 2018-2021
  • Table 17: Incidences of Neurological Disorders in South Korea, By Disease Type, 2018-2021
  • Table 18: Robotic Neurosurgery Market, Product Benchmarking (by Product)
  • Table 19: Key Strategies, January 2022-April 2025